142 related articles for article (PubMed ID: 19520657)
1. Timing of levosimendan in cardiac surgery.
Aksun M; Karahan N; Adanir T; Aran G; Yetkin U; Oztürk T; Sencan A; Ozgürbüz U; Gürbüz A
Anadolu Kardiyol Derg; 2009 Jun; 9(3):223-30. PubMed ID: 19520657
[TBL] [Abstract][Full Text] [Related]
2. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
4. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
5. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
[TBL] [Abstract][Full Text] [Related]
8. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A
Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan for low cardiac output: a pediatric experience.
Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
12. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
Husedzinović I; Barisin S; Bradić N; Barisin A; Sonicki Z; Milanović R
Croat Med J; 2005 Dec; 46(6):950-6. PubMed ID: 16342349
[TBL] [Abstract][Full Text] [Related]
14. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
Metzsch C; Liao Q; Steen S; Algotsson L
Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
17. [The effectiveness of enoximone in patients with serious left ventricular dysfunction submitted for aorto-coronary bypass].
Oppizzi M; Montorsi E; Tosoni A; Casati V; Venturino M; Franco A; Gerli C; Paolillo G
Minerva Anestesiol; 1997; 63(1-2):17-27. PubMed ID: 9213836
[TBL] [Abstract][Full Text] [Related]
18. Post-operative effects of olprinone after coronary artery bypass grafting.
Orime Y; Shiono M; Hata H; Yagi S; Tsukamoto S; Kimura S; Ohmiya S; Sezai A; Yamada H; Obana M; Sezai Y
Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):340-6. PubMed ID: 9914463
[TBL] [Abstract][Full Text] [Related]
19. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
